Epcoritamab

ATC L01FX27 · 11 markets · 24 records

Epcoritamab 11 markets · 24 records Forms

AU 5 records · 5 strengths

  • 4 mg/0.8 mLinjectionEPKINLY also in US·GB·SG +3
  • 48 mg/0.8 mLinjectionEPKINLY also in US·GB·SG +2
  • 60 mg/mLinjectionEPKINLY epcoritamab 48mg/0.8mL solution for injection vial unknown
  • 5 mg/mLinjectionEPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

HK 3 records · 1 strengths

    3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名EPKINLY CONCENTRATE FOR SOLUTION FOR INJECTION 4MG/0.8ML ×1EPKINLY Solution for Injection 48 mg/0.8 mL ×8

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    US 2 records · 2 strengths

    GB 2 records · 2 strengths

    • 4 mg/0.8 mLinjectionTepkinly 4mg/0.8ml concentrate for solution for injection vials also in AU·US·SG +3
    • 48 mg/0.8 mLinjectionTepkinly 48mg/0.8ml solution for injection vials also in AU·US·SG +2

    CA 2 records · 2 strengths

    SG 2 records · 2 strengths

    ES 2 records · 2 strengths

    TW 2 records · 2 strengths

    FR 2 records · 2 strengths

    MX 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.